Porter Mary W, Burdi William, Casavant Jonathan D, Eastment McKenna C, Tulloch-Palomino Luis G
Pharmacy Services, VA Puget Sound Health Care System, Seattle, Washington.
Hospital and Specialty Medicine, VA Puget Sound Health Care System, Seattle, Washington.
Infect Control Hosp Epidemiol. 2022 Dec;43(12):1873-1879. doi: 10.1017/ice.2021.529. Epub 2022 Feb 15.
To describe the association between duration of antimicrobial prophylaxis (AMP) and 30-day surgical site infection (SSI), 7-day acute kidney injury (AKI), 90-day infection (CDI), prolonged hospitalization, and 30-day reoperation after lumbar spine surgery for noninfectious indications, and to report adherence to current guidelines.
Survey.
The study cohort comprised 6,198 patients who underwent lumbar spine surgery for noninfectious indications across 137 Veterans' Health Administration surgery centers between 2016 and 2020.
Used univariate and multivariate logistic regression to determine the association between type and duration of AMP with 30-day SSI, 7-day AKI, 90-day CDI, prolonged hospitalization, and 30-day reoperation.
Only 1,160 participants (18.7%) received the recommended duration of AMP. On multivariate analysis, the use of multiple prophylactic antimicrobials was associated with increased odds of 90-day CDI (adjusted odds ratio [aOR], 5.5; 95% confidence interval [CI], 1.1-28.2) and 30-day reoperation (aOR, 2.3; 95% CI, 1.2-4.4). Courses of antimicrobials ≥3 days were associated with increased odds of prolonged hospitalization (aOR,1.8; 95% CI, 1.4-2.3) and 30-day reoperation (aOR, 3.5; 95% CI, 2.2-5.7). In univariate analysis, increasing days of AMP was associated with a trend toward increasing odds of 90-day CDI (cOR, 1.4; 95% CI, 1.0-1.8 per additional day; = .056).
Longer courses of AMP after lumbar spine surgery were associated with higher odds of CDI, prolonged hospitalization, and reoperation, but not with lower odds of SSI. However, adherence to the recommended duration of AMP is very low, hinting at a wide evidence-to-practice gap that needs to be addressed by spine surgeons and antimicrobial stewardship programs.
描述非感染性指征腰椎手术后抗菌药物预防性使用(AMP)的持续时间与30天手术部位感染(SSI)、7天急性肾损伤(AKI)、90天艰难梭菌感染(CDI)、住院时间延长及30天再次手术之间的关联,并报告对当前指南的依从性。
调查。
研究队列包括2016年至2020年间在137个退伍军人健康管理局手术中心接受非感染性指征腰椎手术的6198例患者。
采用单因素和多因素逻辑回归确定AMP的类型和持续时间与30天SSI、7天AKI、90天CDI、住院时间延长及30天再次手术之间的关联。
仅1160名参与者(18.7%)接受了推荐的AMP持续时间。多因素分析显示,使用多种预防性抗菌药物与90天CDI(调整优势比[aOR],5.5;95%置信区间[CI],1.1 - 28.2)及30天再次手术(aOR,2.3;95%CI,1.2 - 4.4)的几率增加相关。抗菌药物疗程≥3天与住院时间延长(aOR,1.8;95%CI,1.4 - 2.3)及30天再次手术(aOR,3.5;95%CI,2.2 - 5.7)的几率增加相关。单因素分析中,AMP天数增加与90天CDI几率增加呈趋势相关(累积优势比[cOR],1.4;95%CI,每增加一天为1.0 - 1.8;P = 0.056)。
腰椎手术后较长疗程的AMP与CDI几率增加、住院时间延长及再次手术相关,但与SSI几率降低无关。然而,对推荐的AMP持续时间的依从性非常低,这表明存在较大的证据与实践差距,脊柱外科医生和抗菌药物管理计划需要加以解决。